Recalls from Chiesi USA, Inc.

• Revcovi (Elapegademase-Lvlr) Injection (opens in a new tab)
  Low risk, FDA, Aug 28, 2026, Quality testing problem
• Chiesi Cleviprex Clevidipine Injectable Emulsion (opens in a new tab)
  Moderate risk, FDA, Jul 14, 2026, Sterility problem
• Chiesi Curosurf Intratracheal Suspension (opens in a new tab)
  Moderate risk, FDA, Mar 27, 2026, Sterility problem

Data: Recall Canary (opens in a new tab)